Cardioprotection and arrhythmias, Part I

Author： Baczkó István   Jost Norbert   Varró András  

Publisher： NRC Research Press

E-ISSN： 1205-7541|93|7|v-v

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.93, Iss.7, 2015-01, pp. : v-v

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Therapeutic Interventions to Enhance Apolipoprotein A-I-Mediated Cardioprotection

By Haas Michael J.   Mooradian Arshag D.  

Drugs, Vol. 70, Iss. 7, 2010-05 ,pp. : 805-821

Adis International

Access to resources Recommend Favorite

Kinins and Cardioprotection

By Wirth K.J.   Linz W.   Wiemer G.   Scholkens B.A.  

Pharmacological Research, Vol. 35, Iss. 6, 1997-06 ,pp. : 527-530

Academic Press

Access to resources Recommend Favorite

Sildenafil and Cardioprotection

By  

Current Pharmaceutical Design, Vol. 19, Iss. 39, 2013-12 ,pp. : 6842-6847

Bentham Science Publishers

Access to resources Recommend Favorite

QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide

By Miyamoto S.   Zhu B.-M.   Teramatsu T.   Aye N.N.   Hashimoto K.  

European Journal of Pharmacology, Vol. 400, Iss. 2, 2000-07 ,pp. : 263-269

Elsevier

Access to resources Recommend Favorite

Concerning the effect of the K + channel blocking agent glibenclamide on ischaemic and reperfusion arrhythmias - I. A method of coronary occlusion in small animals

By Bernauer W.  

European Journal of Pharmacology, Vol. 326, Iss. 2, 1997-05 ,pp. : 147-156

Elsevier

Access to resources Recommend Favorite